Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports

Brasil Notícia Notícia

Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Brasil Últimas Notícias,Brasil Manchetes

Explore stories from Atlantic Canada.

Seniors displaced after Yarmouth fire | SaltWire #fire #yarmouth #seniors #news -Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the Wall Street Journal reported on Tuesday.

Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and the UK, that seeks to treat patients with sight-threatening diseases.

 

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reportsMerck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reportsExplore stories from Atlantic Canada.
Consulte Mais informação »



Render Time: 2025-01-10 06:46:41